Article

Winds of Change: An Evidence-Based Approach

Interest in the concept of evidence-based medicine is spreading throughout all medical disciplines, and it is making in-roads in ophthalmology as well, according to panelists in an evening CME symposium held Friday at the Astor Crowne Plaza.

New Orleans-Interest in the concept of evidence-based medicine is spreading throughout all medical disciplines, and it is making in-roads in ophthalmology as well, according to panelists in an evening CME symposium held Friday at the Astor Crowne Plaza. Evidence-based medicine is the integration of best research evidence with clinical expertise and patient values.

Stephen C. Pflugfelder, MD, Baylor College of Medicine, Houston, moderated the program, which featured discussions on efficacy and patient perspectives in glaucoma management. Panelists also discussed new developments regarding specific conditions, such as dysfunctional tear syndrome and chronic dry eye disease, as well as evidence supporting the fourth-generation fluoroquinolones. The program closed with a presentation on retinal perspectives on cystoid macular edema diagnosis, treatment, and prevention.

Presenters included Dimitri T. Azar, MD, Harvard Medical School and Massachusetts Eye and Ear Infirmary; Jeffrey S. Heier, MD, Tufts University School of Medicine and Harvard University Medical School, Boston; Francis S. Mah, MD, University of Pittsburgh School of Medicine; Robert J. Noecker, MD, MBA, University of Pittsburgh School of Medicine; Randall J. Olson, MD, University of Utah, Salt Lake City; and Steven T. Simmons, MD, Glaucoma Consultants of the Capitol Region, Albany, New York.

The program was jointly sponsored by Ophthalmology Times and the New York Eye and Ear Infirmary and supported by an unrestricted educational grant from Allergan.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.